Abstract:To find novel and effective anti-cancer agents, sixteen novel imamine-1,3,5-triazine derivatives were firstly designed and synthesized by molecular hybridization strategy and nucleophilic substitution reaction. The sturcutures of imamine-1,3,5-triazine derivatives were characterized by 1H NMR, 13C NMR, IR, HR-MS and single crystal X-ray diffraction. These compounds were tested using the methyl thiazolyl tetrazolium (MTT) assay for their antiproliferative properties against MDA-MB-231 (breast cancer cell), HeLa (cervical cancer cell) and A498 (kidney cancer cell) with imatinib as the positive control which was the parent compound of imamine. The data revealed that some of the imamine-1,3,5-triazine derivatives possessed better anticancer activity than Imatinib. The imamine-1,3,5-triazine derivatives were selective against triple-negative MDA-MB-231 breast cancer cells. Compound 4f (N2-Allyl-6-chloro-N2-methyl-N4-(4-methyl-3-((4-(pyridin-3-yl) pyrimidin-2-yl) amino) phenyl)-1,3,5-triazine-2,4-diamine) and 4k (6-Chloro-N2-cyclohexyl-N2-methyl-N4-(4-methyl-3-((4-(pyridin-3-yl) pyrimidin-2-yl) amino) phenyl)-1,3,5-triazine-2,4-diamine) demonstrated potent anti-proliferative activity against MDA-MB-231 cells with IC50 of 6.25 μM and 8.18 μM respectively surpassing that of imatinib (IC50 = 35.50 μM). Further studies have shown that compound 4f not only inhibits the migration, invasion, adhesion, and proliferation of MDA-MB-231 cells, but also has a strong inhibitory effect on the proliferation of MDA-MB-231 tumor xenografts in vivo. In addition, the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties prediction suggest that these compounds may have the properties of drug candidates. Thus, compound 4f may be a promising drug candidate for the treatment of cancer.

Design, Synthesis and Anti‐Tumor Activity Evaluation of Novel 3,4‐(methylenedioxy)cinnamic Acid Amide‐Dithiocarbamate Derivatives

Synthesis and Antitumor Activity Evaluation of Novel 2-Amino-5-ethylpyrimidine Derivatives

Discovery of Novel Heteroarylmethylcarbamodithioates As Potent Anticancer Agents: Synthesis, Structure-Activity Relationship Analysis and Biological Evaluation.

Design, Synthesis, and Biological Evaluation of the Novel Glycyrrhetinic Acid-Cinnamoyl Hybrids As Anti-Tumor Agents

[Design, Synthesis and Antitumor Activities of Novel E-substituted 2,3-Diaryl Propenoic Acyloxy Phosphonate Derivatives].

Synthesis And Anti-Tumor Study Of 3-Aryl-4-Oxo-Thiazolidin-2-Carboxylic Acid Amides

Synthesis and Biological Evaluation of Diarylthiazole Derivatives As Antimitotic and Antivascular Agents with Potent Antitumor Activity.

Design, synthesis and anti-tumor activity of novel 5-amino-2-(benzylthio) thia-zole-4-carboxamide derivatives

Design, Synthesis, Antitumor Activity Evaluation, and Molecular Dynamics Simulation of Some 2-Aminopyrazine Derivatives

Design, Synthesis and Preliminary Antiproliferative Activity Studies of New Diheteroaryl Thioether Derivatives

Design, synthesis and antitumor activity of novel 4-oxobutanamide derivatives

Design, Synthesis and Antitumor Activity Evaluation Research of Novel 2,4,6-Substituted Pyrimidine Derivatives

Synthesis, Biological Evaluation, and Molecular Docking Studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline Derivatives As Novel Anticancer Agents

Design, Synthesis, and Evaluation of New 2-Oxoquinoline Arylaminothiazole Derivatives As Potential Anticancer Agents.

Design, Synthesis, and Biological Evaluation of Novel 4‐phenoxypyridine Derivatives As Potential Antitumor Agents

Design, synthesis and biological evaluation of 4-(4-aminophenoxy)picolinamide derivatives as potential antitumor agents

Design, Synthesis and Anticancer evaluation of Imamine-1,3,5-triazine derivatives

Design, synthesis and anti-tumor activity studies of novel pyrido[3, 4-d] pyrimidine derivatives

Design, synthesis and biological evaluation of tryptamine salicylic acid derivatives as potential antitumor agents.

Synthesis and Antitumor Activity of Novel Quinazoline Derivatives Containing Acrylamide

Design, Synthesis and Antiproliferative Activity of Novel 5-Nitropyrimidine-2,4-diamine Derivatives Bearing Alkyl Acetate Moiety